Lawsuit Overview
December 12/202/201 - An investor in shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) filed a lawsuit in the U.S. District Court for the Eastern District of Texas over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between November 9, 2020 and December 8, 2021. Plano, TX based R...
You must register (for free) or login to view the entire case.